Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 186.70K | 182.50K | 15.50K | 15.50K | 8.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 186.70K | 182.50K | 15.50K | 15.50K | 8.20K |
| Cost of Revenue | 564.30K | 551.70K | 489.30K | 487.80K | 195.90K |
| Gross Profit | -377.60K | -369.20K | -473.80K | -472.30K | -187.70K |
| SG&A Expenses | 240.40K | 235.00K | 299.40K | 298.40K | 179.80K |
| Depreciation & Amortization | 700.00 | 700.00 | 1.40K | 1.40K | 1.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 805.40K | 787.40K | 790.10K | 787.60K | 377.10K |
| Operating Income | -618.70K | -604.90K | -774.60K | -772.10K | -368.90K |
| Income Before Tax | -703.30K | -687.60K | -869.00K | -866.20K | -532.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -703.30K | -687.60K | -869.00K | -866.20K | -532.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -703.30K | -687.60K | -869.00K | -866.20K | -532.20K |
| EBIT | -618.70K | -604.90K | -774.60K | -772.10K | -368.90K |
| EBITDA | -618.00K | -604.20K | -773.10K | -770.70K | -367.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 490.47M | 490.47M | 353.60M | 353.60M | 201.34M |
| Average Diluted Shares Outstanding | 490.47M | 490.47M | 353.60M | 353.60M | 201.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |